Paper

Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms

Published May 31, 2022 · Patrice D Cani, C. Depommier, M. Derrien

Nature Reviews Gastroenterology & Hepatology

577

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Literature ReviewHighly Cited

Study Snapshot

Akkermansia muciniphila, an intestinal symbiont, improves health by reducing obesity, diabetes, liver steatosis, inflammation, and cancer immunotherapies.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms

References

Citations